We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » SCOTUS Unanimously Decides Against Patenting Isolated DNA
SCOTUS Unanimously Decides Against Patenting Isolated DNA
June 21, 2013
The Supreme Court June 13 dismissed Myriad Genetics’ patent-eligibility claims on the BRCA1 and BRCA2 genes commonly associated with breast and ovarian cancers, while upholding the company’s patents on the diagnostic technology it created from those genes.